1046769-20-3Relevant articles and documents
Discovery and Assessment of Atropisomers of (±)-Lesinurad
Wang, Jianfei,Zeng, Wenqin,Li, Shaohua,Shen, Liang,Gu, Zhengxian,Zhang, Yang,Li, Jian,Chen, Shuhui,Jia, Xiangbo
, p. 299 - 303 (2017)
(+)- and (?)-Lesinurad were isolated as atropisomers from racemic lesinurad for the first time. No interconversion was observed between the two atropisomers under various conditions tested. The two atropisomers showed significant differences in hURAT1 highly expressed HEK293 cell-based inhibition assays, monkey pharmacokinetic studies, and in vitro human recombinant CYP2C9 stability studies. It was speculated that (+)-lesinurad might offer a better hyperuricemia/gout therapy than (?)-lesinurad or the racemate.
Axial chiral isomers and preparation method and pharmaceutical application thereof
-
Paragraph 0123; 0124; 0125, (2016/10/10)
The invention discloses two axial chiral isomers, available medicinal salts thereof, a preparation method thereof, and pharmaceutical application of the two axial chiral isomers or medicinal compositions thereof.
OXAZOLE AND THIAZOLE DERIVATIVES AND THEIR USES 2
-
Page/Page column 66, (2008/12/08)
Compounds of formula (I): wherein A, X, R1, R2, R3, R4, R5, R6 and R8 are as defined in the Specification are useful in the treatment of diseases where enhanced M3 receptor activ